SCHEMBL4757167

SCHEMBL4757167

Cc1cc(Br)c(C(=O)Nc2nc(Cl)c(S(C)(=O)=O)s2)cc1Br

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.43
NPC1 O15118 3/20 0.43
GPR27 Q9NS67 1/20 0.37
ALDH1A1 P00352 6/20 0.37
KDM4E B2RXH2 4/20 0.37
RXFP1 Q9HBX9 3/20 0.37
TP53 P04637 3/20 0.37
TSHR P16473 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CASP3 P42574 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
NPSR1 Q6W5P4 3/20 0.37
GAA P10253 1/20 0.37
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
PIK3CD O00329 2/20 0.36
PIK3CA P42336 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4756962 0.85 NPC1 (0.40) RAB9ANPC1ALDH1A1KDM4ERXFP1
SCHEMBL10114558 0.84 RAB9A (0.39) RAB9ANPC1ALDH1A1KDM4ERXFP1
SCHEMBL4756579 0.81 HSPD1 (0.46) RAB9ANPC1ALDH1A1KDM4ERXFP1
SCHEMBL10114372 0.76 KDM4E (0.38) RAB9ANPC1ALDH1A1KDM4ERXFP1
SCHEMBL4757325 0.76 SORT1 (0.43) RAB9ANPC1ALDH1A1KDM4ETP53
SCHEMBL4756535 0.75 RAB9A (0.57) RAB9ANPC1ALDH1A1KDM4ERXFP1
SCHEMBL4757180 0.73 RAB9A (0.48) RAB9ANPC1ALDH1A1KDM4ERXFP1
SCHEMBL4757138 0.73 RAB9A (0.43) RAB9ANPC1ALDH1A1KDM4ERXFP1
SCHEMBL10114554 0.70 TP53 (0.45) RAB9ANPC1ALDH1A1KDM4ERXFP1
SCHEMBL4756873 0.70 NPC1 (0.43) RAB9ANPC1RXFP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC RAB9A 1694/4885NPC1 585/4885GPR27 3162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.